Tetanus
244
6
10
205
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
104 trials with published results (43%)
Research Maturity
205 completed trials (84% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
1.6%
4 terminated out of 244 trials
98.1%
+11.5% vs benchmark
65%
158 trials in Phase 3/4
51%
104 of 205 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 205 completed trials
Clinical Trials (244)
Phase I Clinical Trial of Adsorbed Tetanus Vaccine
Observation of Immune Persistence in a Clinical Trial of an Adsorbed Tetanus Vaccine
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series
Study to Compare the Efficacy and Safety of Passive Immunization With TNM002 Injection and Human Tetanus Immunoglobulin as Prophylaxis Against Tetanus
Study of BK1803 in Healthy Infants
A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over
A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined Vaccine
Phase I/III Clinical Trial of Adsorbed Tetanus Vaccine
A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
A Study of Tetanus Antibody of Healthy Adults
A Phase Ⅲ Clinical Study of SNA02-48 Injection
A First in Human Study Investigating the Safety of an Unloaded and Loaded (With a Tetanus-containing Vaccine Booster) Microneedle Patch in Healthy Adults
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult Participants
Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old
A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents)
TETANUS Antibody Detection in Saliva Study
Safety Monitoring of Boostagen® Vaccine in Thailand